Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Trading Statement

15 Jan 2014 07:00

RNS Number : 6625X
Plant Health Care PLC
15 January 2014
 

 

15 January 2014

 

 

 

 

Plant Health Care plc

 

("Plant Health Care" or "the Company")

 

Trading Update

 

 

Plant Health Care plc, ("PHC"), a leading provider of novel patent-protected biological products to the global agriculture markets, provides the following update for the 12 months to 31 December 2013 ahead of its full year results announcement on 24 March 2014.

 

Trading continues to be in line with the Board's expectations. The full year results will reflect the implementation of the new strategy that was announced following the US$20 million fundraising completed in April 2013.

 

In September's interim results statement, PHC reported significant progress, most notably:

 

· New management in place in new headquarters in Raleigh, North Carolina

· New Development and Commercial agreements with Arysta LifeScience and others

· Moved to expanded research facilities in Seattle which enhanced and accelerated investment in the discovery and evaluation of a new generation of Harpin products

 

In the second half of the year, implementation of the new strategy has continued:

 

· In July, the Company's agreement with Monsanto was discontinued and PHC recovered its globally licensed rights to Harpin as a seed treatment.

· In September, Jeff Hovey was appointed Chief Financial Officer. Since joining, he has completed the transfer of the Company's administration and accounting functions from Pittsburgh to Raleigh. The Pittsburgh office was closed on 31 December 2013.

· In November, PHC completed the sale of its non-core European distribution activities while retaining a core capability in the UK and Spain to enable the continued exploitation of Europe, South Africa and certain other non-American markets.

 

All of these actions have been achieved in line with the targets set out at the time of the fundraising.

 

The full year results will reflect these changes and will set out the contribution from our continuing activities and those relating to discontinued and non-core activities.

 

~ ENDS ~

 

For further information, please contact:

 

Plant Health Care plc

Paul Schmidt, Chief Executive Officer

Tel: +1 919 926 1600

Liberum Capital - Nomad and Broker

Clayton Bush / Thomas Bective

Tel: +44 (0) 20 3100 2222

Powerscourt

Sophie Moate / Nick Dibden

Tel: +44 (0) 20 7250 1446

 

About Plant Health Care plc: Plant Health Care is a leading provider of patent protected biological products aimed at the agriculture industry that are environmentally beneficial. Through the commercialisation of these products, Plant Health Care is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management.

 

Further information is available at: www.planthealthcare.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFSALLISLIS
Date   Source Headline
21st Aug 20247:00 amRNSCancellation - Plant Health Care plc
20th Aug 202410:59 amRNSForm 8.5 (EPT/NON-RI)
20th Aug 202410:17 amRNSScheme of Arrangement becomes Effective
20th Aug 20247:30 amRNSSuspension - Plant Health Care plc
16th Aug 202410:14 amRNSExercise of Options & Rule 2.9 Announcement
16th Aug 20249:13 amRNSForm 8.5 (EPT/NON-RI)
15th Aug 202412:44 pmRNSCourt sanction of the Scheme of Arrangement
7th Aug 20246:02 pmRNSForm 8.3 - Plant Health Care Plc
7th Aug 20242:01 pmRNSForm 8.3 - Plant Health Care plc
7th Aug 20249:08 amRNSForm 8.3 - Plant Health Care PLC
6th Aug 20243:08 pmRNSResult of Court Meeting and General Meeting
6th Aug 20241:54 pmRNSForm 8.3 - Plant Health Care plc
6th Aug 202412:45 pmRNSHolding(s) in Company
5th Aug 20242:01 pmRNSForm 8.3 - Plant Health Care plc
5th Aug 20241:39 pmRNSResults of Court Meeting and General Meeting
2nd Aug 20242:00 pmRNSForm 8.3 - Plant Health Care plc
2nd Aug 20248:25 amRNSForm 8.3 - Plant Health Care PLC
1st Aug 20249:33 amRNSForm 8.3 - Plant Health Care PLC
1st Aug 20249:03 amRNSForm 8.5 (EPT/NON-RI)
1st Aug 20248:46 amRNSForm 8.3 - PLANT HEALTH CARE PLC
31st Jul 202411:21 amRNSForm 8.3 - Plant Health Care Plc
29th Jul 20241:09 pmRNSHolding(s) in Company
29th Jul 20248:51 amRNSForm 8.3 - PLANT HEALTH CARE PLC
24th Jul 20247:00 amRNSExpanded Recommendations for OBRONA
23rd Jul 20249:20 amRNSForm 8.5 (EPT/NON-RI) - Plant Health Care PLC
22nd Jul 202411:17 amRNSForm 8.5 (EPT/NON-RI)
19th Jul 20242:36 pmRNSForm 8.5 (EPT/NON-RI)
19th Jul 20242:10 pmRNSForm 8.3 - Plant Health Care plc
18th Jul 20249:05 amRNSForm 8.5 (EPT/NON-RI)
17th Jul 20249:03 amRNSForm 8.5 (EPT/NON-RI) - Plant Health Care PLC
16th Jul 20242:48 pmRNSForm 8.3 - Plant Health Care plc
16th Jul 202410:01 amRNSForm 8.5 (EPT/NON-RI)
15th Jul 202411:25 amRNSForm 8.5 (EPT/NON-RI)
15th Jul 202410:58 amRNSForm 8.3 - Plant Health Care Plc
12th Jul 20241:36 pmRNSForm 8.3 - Plant Health Care PLC
11th Jul 20242:28 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 20243:44 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 20242:58 pmRNSPublication and posting of the Scheme Document
10th Jul 20242:03 pmRNSForm 8.3 - Plant Health Care plc
10th Jul 202410:36 amRNSForm 8 (OPD) - Plant Health Care
9th Jul 20241:57 pmRNSForm 8.3 - Plant Health Care plc
9th Jul 202410:19 amRNSForm 8.3 - Plant Health Care plc - Ospraie Ag
8th Jul 20242:00 pmRNSForm 8.3 - Plant Health Care plc
8th Jul 20241:56 pmRNSForm 8.3 - Plant Health Care Plc
4th Jul 20241:40 pmPRNForm 8.3 - Plant Health Care plc
4th Jul 202411:09 amRNSForm 8.3 - Plant Health Care PLC - Amendment
4th Jul 20248:34 amRNSForm 8.3 - Plant Health Care PLC
3rd Jul 20241:57 pmRNSForm 8.3 - Plant Health Care plc
3rd Jul 20249:26 amRNSForm 8.3 - Plant Health Care plc
3rd Jul 20249:07 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.